NCT02025179View on ClinicalTrials.gov

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 14, 2015

Study Completion Date

August 14, 2015

Conditions
Spinal Cord InjuryBone LossOsteoporosis
Interventions
DRUG

Teriparatide

Teriparatide 20 ug daily Sub-Q over 12 months

DEVICE

Vibration

Vibration 10 min/day for 12 months

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Northwestern University

OTHER

NCT02025179 - 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) | Biotech Hunter | Biotech Hunter